Your session is about to expire
← Back to Search
Brain Health PRO for Dementia Prevention (CTU: BHSP Trial)
CTU: BHSP Trial Summary
This trial is designed to develop, implement and evaluate an online educational Brain Health Support Program (BHSP) intervention, called Brain Health PRO (BHPro), with potential to positively influence dementia literacy, lifestyle risk factors, and scale-up to reach the broader Canadian public.
- Dementia Prevention
- Mild Cognitive Impairment
- Cognitive Impairment
CTU: BHSP Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.CTU: BHSP Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are between 60 and 85 years old.You have a CDR score higher than 1 during a phone or video evaluation.You scored less than 13 on the Montreal Cognitive Assessment (MoCA) given through a video call.You can sit comfortably for about 30 minutes.You have been diagnosed with dementia by a doctor.You do not have dementia and you fit into one of these categories: Cognitively Unimpaired, Cognitively Unimpaired with Subjective Cognitive Impairment, or Mild Cognitive Impairment.You have a close family member with dementia, or you have certain health conditions like high blood pressure, high cholesterol, obesity, or are not physically active, which may increase your risk of developing dementia.You cannot see or hear well enough to participate in remote assessments, tests, or online programs.
- Group 1: Brain Health PRO
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does the age criteria for this trial include individuals over the age of forty?
"Patients aged 60-85 can be included in this medical investigation."
Is enrollment for this experiment open at the present moment?
"According to the information provided on clinicaltrials.gov, this medical trial is presently inviting participants. This study was initially posted in April 1st 2022 and underwent an update at the end of May that same year."
How many healthcare facilities are presently carrying out this experiment?
"This trial is being conducted in several locations, including the University of British Columbia located in Vancouver, BC; Baycrest based out of Toronto, ON; and Cognitive Clinical Research Group at Parkwood Institute in London, QC."
Who fulfills the qualifications to participate in this experiment?
"This medical trial is currently seeking 350 elderly individuals aged 60 to 85 who demonstrate signs of cognitive decline. To apply, potential participants must display the following: linguistic aptitude in either English or French, auditory and visual acuity sufficient enough for remote clinical assessment and an online education program, the ability to remain seated comfortably for 30 minutes at a time, no history of dementia amongst first-degree family members; completion and attestation of electronic informed consent forms, technological proficiency with computers/internet access as well as sending/receiving emails; Cognitively Unimpaired (CU) plus Subjective Cognitive Impairment (SCI)."
To what extent is enrollment in this clinical trial progressing?
"In order to complete this clinical trial, 350 qualified patients need to enroll. Those interested can find participating sites near them at the University of British Columbia in Vancouver and Baycrest in Toronto."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger